Should You Get Paid For Your DNA?

Two women; one very rare genetic mutation.

Several years ago, scientists were thrilled to discover two patients, a Dallas mother and a young Zimbabwean woman, with the identical double dose of an extremely rare genetic mutation. Both women were found to have strikingly low cholesterol. That research set off a chase among three top pharmaceutical companies, Amgen, Pfizer and Sanofi, to develop new drugs that could imitate the effects of the mutation, called PCSK9, in driving down cholesterol levels.

Back to news